Business
Kane Biotech Restarts Commercial Activities and Strengthens North American Management
Company enters 2026 with renewed business momentum and key commercial appointments in the U.S. and CanadaWINNIPEG, Manitoba, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces the resumption of commercial activities in both the United States and Canada for its revyve® Antimicrobial Wound Gel product line, alongside the appointment of two seasoned industry leaders to drive business development across North America. US FDA 510(
About this update from Kane Biotech Inc.
[{"type":"image","alt":"Kane Biotech Inc.","displaySize":"","headline":null,"caption":"Kane Biotech Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":100,"url":"https://media.zenfs.com/en/globenewswire.com/8c0bc49cc705de4fa90f6da1d7452d9f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/r6.I5yq30fbtTHkzKWc_gQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/8c0bc49cc705de4fa90f6da1d7452d9f","width":300,"height":100}},"lazy":false},{"type":"text","content":"Company enters 2026 with renewed business momentum and key commercial appointments in the U.S. and Canada","length":105,"tagName":"p"},{"type":"text","content":"WINNIPEG, Manitoba, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces the resumption of commercial activities in both the United States and Canada for its revyve® Antimicrobial Wound Gel product line, alongside the appointment of two seasoned industry leaders to drive business development across North America.","length":383,"tagName":"p"},{"type":"image","alt":"US FDA 510(k) cleared and Health Canada approved revyve Antimicrobial Wound Gel and revyve Antimicrobial Wound Gel Spray","displaySize":"","headline":null,"caption":"US FDA 510(k) cleared and Health Canada approved revyve Antimicrobial Wound Gel and revyve Antimicrobial Wound Gel Spray","className":"","disableSlideshowImg":false,"size":{"original":{"width":175,"height":227,"url":"https://media.zenfs.com/en/globenewswire.com/e0841877de822b41720956b1fd598478"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/cHrTjP007qcYojPp9BKxvA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTI3MjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/e0841877de822b41720956b1fd598478","width":175,"height":227}}},{"type":"text","content":" US FDA 510(k) cleared and Health Canada approved revyve Antimicrobial Wound Gel and revyve Antimicrobial Wound Gel Spray","length":247,"tagName":"p"},{"type":"text","content":"Commercial Restart in the U.S. and Canada: In the U.S., Kane has signed non-exclusive distribution/sales agreements with Medstream Healthcare Solutions, LLC (Dorval, FL) and Patient Care Medical (Austin, TX) with initial sh...